Auto-generated event page
Evaxion plans to file 2025 annual report later today
COPENHAGEN, Denmark, March 5, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platfo...
Score 41
low confidence
1 source posts
Updated Mar 5, 2026, 1:17 PM UTC